tiprankstipranks
Trending News
More News >
Petmed Express (PETS)
NASDAQ:PETS

Petmed Express (PETS) Price & Analysis

Compare
871 Followers

PETS Stock Chart & Stats

$1.77
-$0.25(-5.00%)
At close: 4:00 PM EST
$1.77
-$0.25(-5.00%)

Bulls Say, Bears Say

Bulls Say
Financial StabilityThe business is well-capitalized to make it through the turnaround, with $50M of cash and no debt.
Management StrategyThe new strategy is focused on consolidating brands, improving the supply chain, focusing on customer retention, driving site traffic, improving the marketing approach, and upgrading the technology platforms.
Bears Say
Customer RetentionThe company is likely losing customers to competitors with the absence of promotions.
Financial PerformanceThe business has not shown growth on an organic basis in over 12 quarters, which is largely driven by competitive pressures.
Revenue DeclineQ2 revenue declined 16% to $59.6M, which was below the $66.0M estimate, indicating customers reduced spending or sought promotions from competitors.

Petmed Express News

PETS FAQ

What was Petmed Express’s price range in the past 12 months?
Petmed Express lowest stock price was $1.57 and its highest was $5.58 in the past 12 months.
    What is Petmed Express’s market cap?
    Petmed Express’s market cap is $68.17M.
      When is Petmed Express’s upcoming earnings report date?
      Petmed Express’s upcoming earnings report date is May 11, 2026 which is in 98 days.
        How were Petmed Express’s earnings last quarter?
        Currently, no data Available
        Is Petmed Express overvalued?
        According to Wall Street analysts Petmed Express’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Petmed Express pay dividends?
          Petmed Express pays a Quarterly dividend of $0.3 which represents an annual dividend yield of N/A. See more information on Petmed Express dividends here
            What is Petmed Express’s EPS estimate?
            Petmed Express’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Petmed Express have?
            Petmed Express has 21,369,520 shares outstanding.
              What happened to Petmed Express’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Petmed Express?
              Currently, no hedge funds are holding shares in PETS
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Petmed Express

                PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

                Petmed Express (PETS) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                111
                LifeMD
                Surrozen
                Adagene

                Ownership Overview

                28.99%12.76%<0.01%52.51%
                28.99% Insiders
                <0.01% Other Institutional Investors
                52.51% Public Companies and
                Individual Investors
                Popular Stocks